- Spearhead the development, execution, and analysis of in vivo pharmacology, PK/BD, and toxicology studies.
- Oversee preclinical studies both internally and at contract research organizations (CROs), driving candidate selection and propelling the advancement of development programs and platform innovation.
- Hold a PhD (or Master's) in Pharmacology, Pharmaceutical Sciences, Oncology, Toxicology, or a related field, with at least 2 years of pertinent experience (or 5+ years for non-PhD candidates), or possess an equivalent blend of industry expertise in preclinical drug discovery and development.
- Demonstrate proficiency and firsthand experience with relevant in vivo oncology/pharmacology models.
- Previous involvement in managing and conducting studies with CROs is essential.
- Preference will be given to candidates with research and development experience in antibody-based therapeutics, radiopharmaceuticals, and in vivo im
-
Associate Scientist Contract
1 week ago
GQR Greater Vancouver Regional District, BC, CanadaCome be a part of a pioneering precision oncology venture, leading the charge in developing next-generation targeted radiation therapies. On the cutting edge of drug development, utilizing a unique modular technology platform to administer radioisotopes selectively, effectively e ...
Associate Scientist - Greater Vancouver, Canada - GQR
1 week ago
Description
Come be a part of a pioneering precision oncology venture, leading the charge in developing next-generation targeted radiation therapies. On the cutting edge of drug development, utilizing a unique modular technology platform to administer radioisotopes selectively, effectively eliminating tumor cells while safeguarding healthy tissue. The mission is clear: to swiftly advance a diverse array of safe and efficacious therapies for cancer patients facing limited treatment options.
Key Responsibilities:
Requirements:
*By applying for this position, you agree to receive marketing communication from GQR and agree to our GQR Privacy Policy & GQR Terms of Use. You may unsubscribe at any given time.